About Prime Medicine, Inc. 
Prime Medicine, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 38 Schemes (14.06%)
Foreign Institutions
Held by 48 Foreign Institutions (7.73%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-53 Million
Pharmaceuticals & Biotechnology
USD 693 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.55
-325.32%
11.39






